With over 50 years of manufacturing experience in various biological products and its state-of-the-art equipment and facilities, GC Biopharma offers CMO services for vaccine(sterile vials and PFS) Filling and Finishing. GC Biopharma has two main CMO manufacturing sites; Ochang site, a fully integrated Filling and Finishing facility and Hwasun site, a vaccine specialized facility.
Ochang South Korea
Labelling and Packaging
Ochang site, located in Ochang-eup, Chungcheongbuk-do, is proud to present its fully integrated Filling and Finishing facility, the W&FF(Warehousing and Filling and Finishing). W&FF facility was newly built in 2019 for the purpose of handling all DP operations from filling, packaging to distributing. W&FF has an isolator filling line, a safest method known in manufacturing sterile vial products, as well as a quality packaging line with automatic visual inspection, 100% IPC CCIT and foreign body detection. Its warehouse runs on a fully automated barcoding system, along with WMS(Warehouse Management System) to ensure effective and structural operation on all floors. W&FF is currently able to manufacture deactivated vaccine, protein recombinant and mRNA based products.
WHO Vaccine Plant
Hwasun South Korea
Drug Substances and
Hwasun site, located in Hwasun, Jeollanam-do, is GC Biopharma’s leading vaccine manufacturing site. Hwasun site is known for its WHO approved facility and its pre-WHO approved GC Flu(Quadrivalent Influenza vaccine). Hwasun site manufactures both live attenuated and deactivated vaccines in vials and PFS and is equipped with O-RABS filling line, automated visual inspection and labeling and secondary packaging line.